CAS: 929095-18-1 - GSK-461364
Fórmula:C27H28F3N5O2S
InChI:InChI=1S/C27H28F3N5O2S/c1-17(19-5-3-4-6-20(19)27(28,29)30)37-23-14-24(38-25(23)26(31)36)35-16-32-21-8-7-18(13-22(21)35)15-34-11-9-33(2)10-12-34/h3-8,13-14,16-17H,9-12,15H2,1-2H3,(H2,31,36)/t17-/m1/s1
Clave InChI:InChIKey=ZHJGWYRLJUCMRT-QGZVFWFLSA-N
SMILES:O=C(N)C=1SC(=CC1OC(C=2C=CC=CC2C(F)(F)F)C)N3C=NC=4C=CC(=CC43)CN5CCN(C)CC5
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | GSK461364 REF: TM-T6282CAS: 929095-18-1 | 99.5% | 37,00 €~1.189,00 € | Jue 30 May 24 |
 | GSK 461364 REF: TR-G797705CAS: 929095-18-1 | - - - | 93,00 €~152,00 € | Mié 03 Jul 24 |
 | GSK 461364 REF: 3D-FM43315CAS: 929095-18-1 | Min. 95% | A consultar | Vie 05 Jul 24 |
GSK461364
CAS:929095-18-1
GSK461364 (GSK461364A)(Ki=2.2 nM) inhibits purified Plk1 .The specificity of GSK461364 for Plk1 is more than …
Fórmula:
C27H28F3N5O2S
Pureza:
99.5%
Forma y color:
Solid
Peso molecular:
543.6
Ref: TM-T6282
| 1mg | 37,00 € | |
| 2mg | 52,00 € | |
| 5mg | 73,00 € | |
| 10mg | 121,00 € | |
| 25mg | 202,00 € | |
| 50mg | 365,00 € | |
| 100mg | 549,00 € | |
| 200mg | 779,00 € | |
| 500mg | 1.189,00 € | |
| 1ml*10 (DMSO) | 88,00 € |
Entrega estimada en Estados Unidos, el Jueves 30 de Mayo de 2024
GSK 461364
CAS:929095-18-1
Applications GSK 461364 is a dose-dependant inhibitor of proliferating cancer cell lines as well as …
Fórmula:
C27H28F3N5O2S
Forma y color:
Neat
Peso molecular:
543.6
Ref: TR-G797705
| 5mg | 152,00 € | |
| 2500µg | 93,00 € |
Entrega estimada en Estados Unidos, el Miércoles 3 de Julio de 2024
GSK 461364
CAS:929095-18-1
A selective ATP-competitive inhibitor of polo-like kinase 1 (Plk1). This protein is a serine/threonine kinase …
Fórmula:
C27H28F3N5O2S
Pureza:
Min. 95%
Peso molecular:
543.6 g/mol
Ref: 3D-FM43315
| 10mg | A consultar | |
| 50mg | A consultar | |
| 100mg | A consultar | |
| 250mg | A consultar | |
| 500mg | A consultar |
Entrega estimada en Estados Unidos, el Viernes 5 de Julio de 2024
